Cancer stem cells in osteosarcoma

被引:236
|
作者
Brown, Hannah K. [1 ,2 ]
Tellez-Gabriel, Marta [3 ]
Heymann, Dominique [1 ,2 ,4 ]
机构
[1] Univ Sheffield, Sch Med, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Sheffield, INSERM, European Associated Lab, Sarcoma Res Unit,Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
[3] Hosp Santa Creui St Pau, Inst Invest Biomed IBB St Pau, Lab Hematol Oncol & Transplantes, Barcelona 08025, Spain
[4] Univ Nantes, Fac Med, INSERM,Equipe Ligue 2012, UMR 957,Pathophysiol Bone Resorpt & Therapy Prima, F-44035 Nantes, France
关键词
Osteosarcoma; Bone cancer; Cancer stem cell; Tumour heterogeneity; SIDE POPULATION CELLS; DECIPHERING INTRATUMOR HETEROGENEITY; TUMOR-INITIATING CELLS; CD133; EXPRESSION; DRUG-RESISTANCE; BONE SARCOMAS; SELF-RENEWAL; SOLID TUMORS; ACTIVATION; DRIVER;
D O I
10.1016/j.canlet.2016.11.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteosarcoma is the most common primary bone tumour in children and adolescents and advanced osteosarcoma patients with evidence of metastasis share a poor prognosis. Osteosarcoma frequently gains resistance to standard therapies highlighting the need for improved treatment regimens and identification of novel therapeutic targets. Cancer stem cells (CSC) represent a sub-type of tumour cells attributed to critical steps in cancer including tumour propagation, therapy resistance, recurrence and in some cases metastasis. Recent published work demonstrates evidence of cancer stem cell phenotypes in osteosarcoma with links to drug resistance and tumorigenesis. In this review we will discuss the commonly used isolation techniques for cancer stem cells in osteosarcoma as well as the identified biochemical and molecular markers. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 50 条
  • [21] Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
    Jubelin, Camille
    Munoz-Garcia, Javier
    Cochonneau, Denis
    Moranton, Emilie
    Heymann, Marie-Francoise
    Heymann, Dominique
    CANCER DRUG RESISTANCE, 2022, 5 (01) : 184 - 198
  • [22] IDENTIFICATION OF CANCER STEM CELLS IN OSTEOSARCOMA CELL LINES: CHARACTERIZATION OF CANCER STEM CELL MARKERS EXPRESSION AND IN VIVO TUMORIGENICITY
    Skoda, J.
    Neradil, J.
    Zambo, I.
    Hermanova, M.
    Sterba, J.
    Veselska, R.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S269 - S269
  • [23] Hypoxia upregulates calpain-6 expression in osteosarcoma cells: implication in cancer stem cells
    Kaci, Imene
    Mansouri, Rafik
    Marie, Pierre
    Modrowski, Dominique
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [24] Modeling of osteosarcoma with induced pluripotent stem cells
    Pang, Lon Kai
    Pena, Mezthly
    Zhao, Ruiying
    Lee, Dung-Fang
    STEM CELL RESEARCH, 2020, 49
  • [25] ESTABLISHMENT AND CHARACTERIZATION OF MOUSE OSTEOSARCOMA STEM CELLS
    Shimizu, T.
    Saya, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 61 - 61
  • [26] Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells
    Daniela I. Paiva-Oliveira
    Sara R. Martins-Neves
    Antero J. Abrunhosa
    Carlos Fontes-Ribeiro
    Célia M. F. Gomes
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 49 - 63
  • [27] Osteosarcoma contains a subpopulation of cancer stem-like cells that are highly resistant to radiotherapy
    Sara RM Neves
    Aurio OG Lopes
    Anália do Carmo
    Antero J Abrunhosa
    Paulo CPS Simões
    Artur A Paiva
    M Filomena Botelho
    Célia MF Gomes
    BMC Proceedings, 4 (Suppl 2)
  • [28] Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition
    Peng, Lihua
    Jiang, Dianming
    PLOS ONE, 2018, 13 (10):
  • [29] Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells
    Paiva-Oliveira, Daniela I.
    Martins-Neves, Sara R.
    Abrunhosa, Antero J.
    Fontes-Ribeiro, Carlos
    Gomes, Celia M. F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (01) : 49 - 63
  • [30] Stem cells, cancer, and cancer stem cells
    Tannishtha Reya
    Sean J. Morrison
    Michael F. Clarke
    Irving L. Weissman
    Nature, 2001, 414 : 105 - 111